Johnson & Johnson (JNJ) Tops Q1 EPS by 6c

(Updated - April 16, 2019 6:43 AM EDT)

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.10, $0.06 better than the analyst estimate of $2.04. Revenue for the quarter came in at $20.02 billion versus the consensus estimate of $19.61 billion.

GUIDANCE:

Johnson & Johnson sees FY2019 EPS of $8.53-$8.63, versus the consensus of $8.58. Johnson & Johnson sees FY2019 revenue of $80.4-81.2 billion, versus the consensus of $81.05 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Globalwafers Co Ltd. (6488:TT) PT Raised to NT$1,200 at Nomura/Instinet
• UBS Downgrades EasyJet Plc. (EZJ:LN) (ESYJY) to Neutral